Table 2.

Tumor stage and histology according to gender

Group 1 (n = 122)Group 2 (n = 249)Group 3 (n = 122)Group 4 (n = 81)
MaleFemaleMaleFemaleMaleFemaleMaleFemale
(n = 68)(n = 54)(n = 201)(n = 48)(n = 51)(n = 71)(n = 43)(n = 38)
Tumor type, n (%)
 NSCLC0 (0.0)0 (0.0)185 (92.0)46 (95.8)51 (100.0)71 (100.0)28 (65.1)21 (55.3)
 SCLC68 (100.0)54 (100.0)4 (2.0)0 (0.0)0 (0.0)0 (0.0)14 (32.6)16 (42.1)
 Unknown0 (0.0)0 (0.0)12 (6.0)2 (4.2)0 (0.0)0 (0.0)1 (2.3)1 (2.6)
NSCLC stage, n (%)
 I0 (0.0)0 (0.0)105 (56.8)22 (47.8)30 (58.8)41 (57.7)5 (17.9)1 (4.8)
 II0 (0.0)0 (0.0)16 (8.6)7 (15.2)15 (29.4)16 (22.5)1 (3.6)0 (0.0)
 III0 (0.0)0 (0.0)40 (21.6)11 (23.9)6 (11.8)12 (16.9)3 (10.7)3 (14.3)
 IV0 (0.0)0 (0.0)16 (8.6)0 (0.0)0 (0.0)2 (2.8)3 (10.7)5 (23.8)
 Unknown0 (0.0)0 (0.0)8 (4.3)6 (13.0)0 (0.0)0 (0.0)16 (57.1)12 (57.1)
NSCLC histology, n (%)
 Squamous0 (0.0)0 (0.0)87 (47.0)11 (23.9)23 (45.1)7 (9.9)15 (53.6)4 (19.0)
 Adenocarcinoma0 (0.0)0 (0.0)77 (41.6)30 (65.2)25 (49.0)58 (81.7)4 (14.3)10 (47.6)
 Large cell0 (0.0)0 (0.0)5 (2.7)3 (6.5)3 (5.9)2 (2.8)0 (0.0)0 (0.0)
 Not determined0 (0.0)0 (0.0)16 (8.6)2 (4.3)0 (0.0)4 (5.6)9 (32.1)6 (28.6)
 Other0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)1 (4.8)
SCLC stage, n (%)
 Limited SCLC21 (30.9)17 (31.5)0 (0.0)0 (0.0)0 (0.0)0 (0.0)4 (28.6)6 (37.5)
 Extensive SCLC47 (69.1)37 (68.5)0 (0.0)0 (0.0)0 (0.0)0 (0.0)9 (64.3)8 (50.0)
 Not determined0 (0.0)0 (0.0)4 (100.0)0 (0.0)0 (0.0)0 (0.0)1 (7.1)2 (12.5)